Cargando…
High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study
BACKGROUND: Pain is a common feature of hemophilia, but prevalence of depression and anxiety is less studied. Registry data on prescription drugs can provide an objective measure of the magnitude of these complications. OBJECTIVES: To identify treatment patterns of prescribed pain, antidepressant, a...
Autores principales: | Steen Carlsson, Katarina, Winding, Bent, Astermark, Jan, Baghaei, Fariba, Brodin, Elisabeth, Funding, Eva, Holmström, Margareta, Österholm, Klaus, Bergenstråle, Sofia, Lethagen, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999211/ https://www.ncbi.nlm.nih.gov/pubmed/36908766 http://dx.doi.org/10.1016/j.rpth.2023.100061 |
Ejemplares similares
-
Pain, depression and anxiety in people with haemophilia from three Nordic countries: Cross‐sectional survey data from the MIND study
por: Steen Carlsson, Katarina, et al.
Publicado: (2022) -
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
por: Astermark, Jan, et al.
Publicado: (2023) -
Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B
por: Shapiro, Amy D., et al.
Publicado: (2018) -
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
por: Shapiro, Amy D., et al.
Publicado: (2022) -
Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies
por: Chowdary, Pratima, et al.
Publicado: (2022)